Paraganglioma del filum terminal como causa de síndrome de cauda equina

Undabeitia-Huertas, José; Noboa, R.; Jové, Ramón Pedragosa; Boix, Marcos Postigo; Gatius, Sònia; Nogues, Pere

doi:10.4321/s1137-66272013000200021

Cited by 7 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Navar. 2014; 37 (1): [137][138] cartas / opinión0 paraganglioma de cauda equina Paraganglioma of the cauda equina M. Gelabert-González, E. aran-Echabe y r. serramito-García sr. Director:…”

unclassified

Paraganglioma de cauda equina

Gelabert-González

Arán-Echabe

Serramito-García

2014

Anales Sis San Navarra

View full text Add to dashboard Cite

unclassified

Paraganglioma de cauda equina

Gelabert-González

Arán-Echabe

Serramito-García

2014

Anales Sis San Navarra

View full text Add to dashboard Cite

Paraganglioma of the cauda equina: a tertiary centre experience and scoping review of the current literature

et al. 2021

View full text Add to dashboard Cite

Cauda equina paragangliomas are rare benign extra-adrenal neuroendocrine tumours arising from the neural crest cells associated with autonomic ganglia. These tumours are often mistaken preoperatively for ependymomas or schwannomas. Patients present with axial or radicular pain with or without neurological deficits. Recurrence, secretory features and length of follow-up are controversial. We conducted a retrospective cohort study of paraganglioma through searching a prospectively maintained histopathology database. Patient demographics, presentation, surgery, complications, recurrence, follow-up and outcome between 2004 and 2016 were studied. The primary aim was to collate and describe the current evidence base for recurrence and secretory features of the tumour. The secondary objective was to report outcome and follow-up strategy. A scoping review was performed in accordance with the PRISMA-ScR Checklist. Ten patients were diagnosed (M:F 7:3) with a mean age of 53.6 ± 5.1 (range 34–71 years). MRI scans revealed intradural lumbar enhancing lesions. All patients had complete microsurgical excisions without adjuvant therapy with no recurrence with a mean follow-up of 5.1 ± 1.4 years. Tumours were attached to the filum terminale. Electron microscopic images demonstrated abundant neurosecretory granules with no evidence of catecholamine production. A total of 620 articles were screened and 65 papers (including ours) combining 121 patients (mean age 48.8 and M:F 71:50) were included. The mean follow-up was 3.48 ± 0.46 (range 0.15–23 years). Back pain was the most common symptom (94%). Cure following surgery was achieved in 93% of the patients whilst 7% had recurrence. Total resection likely results in cure without the need for adjuvant therapy or prolonged follow-up. However, in certain situations, the length of follow-up should be determined by the treating surgeon.

show abstract